Nothing Special   »   [go: up one dir, main page]
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling

Oncogene volume 33, pages 4531–4536 (2014)Cite this article

Subjects

Abstract

Desmosomal cadherins mediate cell–cell adhesion in epithelial tissues and have been known to be altered in cancer. We have previously shown that one of the two intestinal epithelial desmosomal cadherins, desmocollin-2 (Dsc2) loss promotes colonic epithelial carcinoma cell proliferation and tumor formation. In this study we show that loss of the other intestinal desmosomal cadherin, desmoglein-2 (Dsg2) that pairs with Dsc2, results in decreased epithelial cell proliferation and suppressed xenograft tumor growth in mice. Dsg2-deficient cells demonstrated a compensatory increase in Dsc2 expression, and small interfering RNA-mediated loss of Dsc2 restored proliferation in Dsg2-deficient cells. Dsg2 downregulation inhibited epidermal growth factor receptor (EGFR) signaling and cell proliferation through altered phosphorylation of EGFR and downstream extracellular signal-regulated kinase activation in parallel with inhibited EGFR receptor internalization. Additionally, we demonstrated a central role of Dsc2 in controlling EGFR signaling and cell proliferation in intestinal epithelial cells. Consistent with these findings, analyses of human colon cancers demonstrated increased Dsg2 protein expression. Taken together, these data demonstrate that partner desmosomal cadherins Dsg2 and Dsc2 play opposing roles in controlling colonic carcinoma cell proliferation through differential effects on EGFR signaling.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Holthofer B, Windoffer R, Troyanovsky S, Leube RE . Structure and function of desmosomes. Int Rev Cytol 2007; 264: 65–163.

    Article  PubMed  Google Scholar 

  2. Getsios S, Amargo EV, Dusek RL, Ishii K, Sheu L, Godsel LM et al. Coordinated expression of desmoglein 1 and desmocollin 1 regulates intercellular adhesion. Differentiation 2004; 72: 419–433.

    Article  CAS  PubMed  Google Scholar 

  3. Tselepis C, Chidgey M, North A, Garrod D . Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci USA 1998; 95: 8064–8069.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Schlegel N, Meir M, Heupel WM, Holthofer B, Leube RE, Waschke J . Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol 2010; 298: G774–G783.

    Article  CAS  PubMed  Google Scholar 

  5. Brennan D, Hu Y, Joubeh S, Choi YW, Whitaker-Menezes D, O'Brien T et al. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J Cell Sci 2007; 120: 758–771.

    Article  CAS  PubMed  Google Scholar 

  6. Mannan T, Jing S, Foroushania SH, Fortune F, Wan H . RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation. Cell Prolif 2011; 44: 301–310.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kolegraff K, Nava P, Helms MN, Parkos CA, Nusrat A . Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling. Mol Biol Cell 2011; 22: 1121–1134.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Biedermann K, Vogelsang H, Becker I, Plaschke S, Siewert JR, Hofler H et al. Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer. J Pathol 2005; 207: 199–206.

    Article  CAS  PubMed  Google Scholar 

  9. Brennan D, Mahoney MG . Increased expression of Dsg2 in malignant skin carcinomas: a tissue-microarray based study. Cell Adh Migr 2009; 3: 148–154.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Wex T, Kuester D, Monkemuller K, Stahr A, Fry LC, Kandulski A et al. Assessment of desmosomal components (desmoglein 1-3, plakoglobin) in cardia mucosa in relation to gastroesophageal reflux disease and Helicobacter pylori infection. Hum Pathol 2012; 43: 1745–1754.

    Article  PubMed  Google Scholar 

  11. Baron S, Hoang A, Vogel H, Attardi LD . Unimpaired skin carcinogenesis in Desmoglein 3 knockout mice. PLoS One 2012; 7: e50024.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lock JG, Stow JL . Rab11 in recycling endosomes regulates the sorting and basolateral transport of E-cadherin. Mol Biol Cell 2005; 16: 1744–1755.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Getsios S, Simpson CL, Kojima S, Harmon R, Sheu LJ, Dusek RL et al. Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol 2009; 185: 1243–1258.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ . c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 1999; 274: 8335–8343.

    Article  CAS  PubMed  Google Scholar 

  15. Oksvold MP, Thien CB, Widerberg J, Chantry A, Huitfeldt HS, Langdon WY . Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor. Oncogene 2003; 22: 8509–8518.

    Article  CAS  PubMed  Google Scholar 

  16. Hynes NE, Lane HA . ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 2005; 5: 341–354.

    Article  CAS  PubMed  Google Scholar 

  17. Ishii K, Norvell SM, Bannon LJ, Amargo EV, Pascoe LT, Green KJ . Assembly of desmosomal cadherins into desmosomes is isoform dependent. J Invest Dermatol 2001; 117: 26–35.

    Article  CAS  PubMed  Google Scholar 

  18. Nava P, Laukoetter MG, Hopkins AM, Laur O, Gerner-Smidt K, Green KJ et al. Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell 2007; 18: 4565–4578.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Resnik N, Sepcic K, Plemenitas A, Windoffer R, Leube R, Veranic P . Desmosome assembly and cell-cell adhesion are membrane raft-dependent processes. J Biol Chem 2011; 286: 1499–1507.

    Article  CAS  PubMed  Google Scholar 

  20. Chen YJ, Chang JT, Lee L, Wang HM, Liao CT, Chiu CC et al. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene 2007; 26: 467–476.

    Article  CAS  PubMed  Google Scholar 

  21. Kolegraff K, Nava P, Laur O, Parkos CA, Nusrat A . Characterization of full-length and proteolytic cleavage fragments of desmoglein-2 in native human colon and colonic epithelial cell lines. Cell Adh Migr 2011; 5: 306–314.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 1989; 49: 2128–2133.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the 12th Glaxo-SmithKline International Award from Japan Society of Immunology and Allergology in Otolaryngology (RK), an American Gastroenterological Association Research Scholar Award (PN), a Crohn’s and Colitis Foundation of America Career Development Award (PN), a CONACyT grant 175854 (PN) and National Institutes of Health grants DK061379, DK072564 (CAP), DK055679, DK059888 (AN) and DDRDC DK064399.

Author information

Author notes

  1. R Kamekura and K N Kolegraff: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Epithelial Pathobiology and Mucosal Inflammation Research Unit, Emory University, GA, Atlanta, USA

    R Kamekura, K N Kolegraff, R S Hilgarth, M Feng, C A Parkos & A Nusrat

  2. Department of Physiology, Biophysics and Neuroscience, Center for Research and Advanced Studies (CINVESTAV), DF, Mexico, Mexico

    P Nava

Authors
  1. R Kamekura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K N Kolegraff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Nava
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R S Hilgarth
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C A Parkos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Nusrat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Nusrat.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kamekura, R., Kolegraff, K., Nava, P. et al. Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling. Oncogene 33, 4531–4536 (2014). https://doi.org/10.1038/onc.2013.442

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2013.442

Keywords

This article is cited by

Search

Advanced search

Quick links